Opaleye Management as of March 31, 2021
Portfolio Holdings for Opaleye Management
Opaleye Management holds 58 positions in its portfolio as reported in the March 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ocular Therapeutix (OCUL) | 15.6 | $106M | 6.5M | 16.41 | |
Chimerix (CMRX) | 6.4 | $43M | 4.5M | 9.64 | |
Protara Therapeutics Com Stk (TARA) | 5.9 | $40M | 2.6M | 15.74 | |
Bridgebio Pharma (BBIO) | 5.3 | $36M | 584k | 61.60 | |
Codexis (CDXS) | 4.7 | $32M | 1.4M | 22.89 | |
Eton Pharmaceuticals (ETON) | 4.3 | $30M | 4.0M | 7.32 | |
Macrogenics (MGNX) | 3.1 | $21M | 666k | 31.85 | |
Tracon Pharmaceuticals Com New (TCON) | 3.0 | $21M | 2.5M | 8.23 | |
Harrow Health (HROW) | 3.0 | $21M | 3.1M | 6.75 | |
Celldex Therapeutics Com New (CLDX) | 3.0 | $20M | 985k | 20.60 | |
Xoma Corp Del Com New (XOMA) | 2.6 | $18M | 438k | 40.81 | |
Stereotaxis Com New (STXS) | 2.5 | $17M | 2.5M | 6.72 | |
Neoleukin Therapeutics | 2.2 | $15M | 1.2M | 12.31 | |
Fortress Biotech | 2.0 | $14M | 3.9M | 3.53 | |
Cytokinetics Com New (CYTK) | 2.0 | $14M | 580k | 23.26 | |
Autolus Therapeutics Sponsored Ads (AUTL) | 1.8 | $12M | 2.1M | 5.73 | |
Gemini Therapeutics | 1.6 | $11M | 811k | 13.55 | |
Deciphera Pharmaceuticals (DCPH) | 1.5 | $10M | 222k | 44.84 | |
Seres Therapeutics (MCRB) | 1.4 | $9.8M | 300k | 32.68 | |
Keros Therapeutics (KROS) | 1.4 | $9.7M | 158k | 61.55 | |
Checkpoint Therapeutics | 1.3 | $9.2M | 2.9M | 3.14 | |
Proqr Therapeutics Nv Shs Euro (PRQR) | 1.3 | $8.6M | 1.3M | 6.61 | |
Essa Pharma Com New (EPIX) | 1.2 | $8.3M | 284k | 29.05 | |
Acutus Medical (AFIB) | 1.2 | $8.2M | 615k | 13.37 | |
Adamas Pharmaceuticals | 1.2 | $8.0M | 1.7M | 4.80 | |
Cerecor | 1.2 | $7.9M | 2.6M | 3.02 | |
Sutro Biopharma (STRO) | 1.1 | $7.8M | 342k | 22.76 | |
Protagonist Therapeutics (PTGX) | 1.1 | $7.7M | 297k | 25.90 | |
Immunovant (IMVT) | 1.1 | $7.5M | 467k | 16.04 | |
Vaxcyte (PCVX) | 1.0 | $7.1M | 358k | 19.75 | |
Sanara Medtech (SMTI) | 1.0 | $7.0M | 225k | 31.15 | |
Catalyst Biosciences Com New | 0.9 | $6.3M | 1.3M | 5.04 | |
Aveo Biosciences Com New | 0.9 | $6.1M | 835k | 7.32 | |
Kiniksa Pharmaceuticals Com Cl A (KNSA) | 0.9 | $5.9M | 321k | 18.51 | |
Verastem | 0.8 | $5.7M | 2.3M | 2.47 | |
Tela Bio (TELA) | 0.8 | $5.4M | 365k | 14.90 | |
Mei Pharma Com New | 0.8 | $5.3M | 1.6M | 3.43 | |
Cardiff Oncology (CRDF) | 0.8 | $5.3M | 576k | 9.26 | |
Sio Gene Therapies | 0.8 | $5.2M | 2.0M | 2.61 | |
Aptose Biosciences Com New | 0.8 | $5.2M | 872k | 5.97 | |
Myovant Sciences | 0.8 | $5.1M | 250k | 20.58 | |
Fibrogen (FGEN) | 0.7 | $5.1M | 147k | 34.71 | |
Lumos Pharma (LUMO) | 0.6 | $4.4M | 377k | 11.70 | |
Kezar Life Sciences (KZR) | 0.6 | $4.2M | 711k | 5.96 | |
Optinose (OPTN) | 0.4 | $3.0M | 826k | 3.69 | |
Highcape Capital Acquisition Corp Com Cl A | 0.4 | $2.9M | 241k | 11.92 | |
Crinetics Pharmaceuticals In (CRNX) | 0.4 | $2.9M | 188k | 15.28 | |
Edap Tms Sa Sponsored Adr (EDAP) | 0.4 | $2.9M | 341k | 8.40 | |
Sierra Oncology Com New | 0.4 | $2.6M | 151k | 17.23 | |
Biohaven Pharmaceutical Holding | 0.3 | $1.7M | 25k | 68.36 | |
Alpine Immune Sciences (ALPN) | 0.2 | $1.7M | 157k | 10.60 | |
Aerpio Pharmaceuticals | 0.2 | $1.3M | 1.0M | 1.29 | |
Ayala Pharmaceuticals Incorporated | 0.2 | $1.2M | 109k | 10.91 | |
Contrafect Corp Com New | 0.2 | $1.2M | 244k | 4.80 | |
Magenta Therapeutics | 0.2 | $1.0M | 88k | 11.84 | |
Viracta Therapeutics (VIRX) | 0.1 | $958k | 104k | 9.25 | |
Leap Therapeutics | 0.1 | $737k | 388k | 1.90 | |
Biolinerx Sponsored Ads (BLRX) | 0.0 | $47k | 17k | 2.82 |